Whales with a lot of money to spend have taken a noticeably bullish stance on Ascendis Pharma.
Looking at options history for Ascendis Pharma ASND we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $318,202 and 5, calls, for a total amount of $275,293.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $140.0 and $150.0 for Ascendis Pharma, spanning the last three months.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Ascendis Pharma options trades today is 22.67 with a total volume of 1,853.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Ascendis Pharma's big money trades within a strike price range of $140.0 to $150.0 over the last 30 days.
Ascendis Pharma Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASND | PUT | SWEEP | BULLISH | 05/17/24 | $15.0 | $14.0 | $14.0 | $140.00 | $123.3K | 48 | 402 |
| ASND | PUT | SWEEP | BULLISH | 05/17/24 | $15.0 | $14.0 | $14.33 | $140.00 | $82.0K | 48 | 308 |
| ASND | CALL | SWEEP | BULLISH | 05/17/24 | $19.8 | $16.9 | $17.0 | $145.00 | $78.2K | 0 | 217 |
| ASND | CALL | SWEEP | BEARISH | 05/17/24 | $20.0 | $17.7 | $17.7 | $145.00 | $77.8K | 0 | 141 |
| ASND | PUT | SWEEP | BULLISH | 05/17/24 | $14.8 | $13.4 | $14.0 | $140.00 | $71.4K | 48 | 465 |
About Ascendis Pharma
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Having examined the options trading patterns of Ascendis Pharma, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Ascendis Pharma Standing Right Now?
- Currently trading with a volume of 147,456, the ASND's price is down by -2.86%, now at $146.72.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 13 days.
Expert Opinions on Ascendis Pharma
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $200.0.
- An analyst from JP Morgan has decided to maintain their Overweight rating on Ascendis Pharma, which currently sits at a price target of $167.
- An analyst from Wells Fargo persists with their Overweight rating on Ascendis Pharma, maintaining a target price of $260.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $173.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Ascendis Pharma with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
